Pyridine 3-carboxillic acid 1 on treatment with phosphorous pentachloride and anhydrous carbon tetrachloride followed by reaction with hydrazine hydrate gave nicotinohydrazide 2. And compound 2 on further reaction with acetyl acetone, ethyl acetoacetate, ethylcyanoacetate and different substituted aromatic acids yielded the corresponding (3,5-dimethyl-1H-pyrazol-1-yl)(pyridine-3-yl)methanone 3, 3-methyl-1-nicotinoyl-1H-pyrazol-5(4H)-one 4, 3-amino-1-nicotinoyl-1H-pyrazol-5(4H)-one 5 and 3-(5-substituted-1,3,4 oxadiazole) pyridine 6a-d, respectively. All the synthesized compounds have been screened for their antimycobacterial activity.
Introduction
Heterocycles containing pyridine rings are associated with a wide range of biological properties such as anticonvulsant 1 , antiparkinsonian 2 , antiinflammatory 2 , antitumor 3, 4 , antimalarial 5 , antimicrobial 5, 6, 7 , antimycobacterial 8, 9 activities due to toxophoric -N=C-group. Pyrazole represent one of the most active classes of compounds possessing a wide spectrum of biological activities, such as antiinflammatory 10 , antipyretic, analgesic and smooth muscle relaxant 11 activities. Many pyrazole derivatives are associated with antifungal, antidiabetic 12 and bactericidal 13 activities. Large number of oxadiazole derivatives reported in the literature possesses a broad spectrum of pharmacological activity such as antimicrobial, antimalarial, anticonvulsant, anticancer, cyclooxygenase, anti HIV property 14 and anti-inflammatory 15 activities. In the present study we have aimed to achieve a better antimycobacterial profile at lower concentrations, by preparing nicotinic acid hydrazide derivatives. This report deals with the synthesis of nicotinic acid hydrazide derivatives and screening for their antimicrobial and antimycobacterial activities.
Materials and Methods
The starting material, nicotinic acid 1 was prepared in laboratory. Melting points were determined in open capillary tubes and are uncorrected. (7), 122 (38), 106 (100).
Synthesis of 3, 4 and 5
To a solution of 2 (0.001mole) in ethanol (10 mL), appropriate diketone ethylacetoacetate/ acetyl acetone/ ethylcynoacetate, 0.002 mol) was added and the reaction mixture was refluxed on a water-bath for 12 hrs in presence of catalytic amount of glacial acetic acid (2-3 drops). The reaction contents were cooled to RT and the obtained product (3,4,5) was filtered, dried and purified by recrystallization from ethanol. 
Synthesis of 3-(5-substituted-1,3,4 oxadiazole) pyridine (6a-d)
A mixture of 2 (0.001mole), substituted aromatic acid(s) (0.002mole) and phosphorous oxichloride (15 mL) was refluxed on oil bath at 100-110 o C for 6 hrs.
The excess of phosphorous oxichloride was distilled off and cooled residue was poured into icecold water. The content were neutralized with ammonia to offered crude product(s) 8a-d, which were filtered, dried and purified by recrystallization from 1,4-dioxane. 
Antimicrobial activity
The in-vitro biological screening of the synthesized compounds was undertaken against the bacteria species, namely, Staphylococcus aureus, Escherichia coli, and Bacillus subtilus and fungi species, namely, Aspergillus niger and Candida albicans by cup-plate method 6, 7 using nutrient agar as a medium. The holes of 6mm diameter were punched carefully using a sterile cork borer and these were filled with test solutions (1000 μg/ml in DMF) and DMF was used as control. The plates were incubated at 37 o C for 24 hrs in case of antibacterial activity and antifungal activity, respectively. The diameter of the zone of inhibition for all the test compounds was measured and the results were compared with the standard drug gentamycin for antibacterial activity and Nystatin for antifungal activity (Table 1) . Perimeter wells of the plate were filled with sterile water to avoid dehydration of the medium during incubation. A standard bacterial suspension equivalent in turbidity to that of a no. 1 McFarland standard was prepared and diluted 1:20 in 7H9 broth; a 100 ml inoculum was used to inoculate each well of the plate. A growth control containing no test compound and a sterile control without inoculum were also included e. Plates were sealed and incubated at 37 0 C for 1 week. 25μL of 0.02% resazurin (Sigma Chem. Co.) Solution was added to each well; plates were re-incubated for an additional 2 days. A change in colour from blue to pink indicated the reduction of resazurin and therefore bacterial growth, and the MIC was read as the minimum test compound concentration that prevented the colour change in resazurin solution (Table 2) .
Antimycobacterial activity

Results and Discussion
The synthesized compounds were evaluated for their antimicrobial as well as antimycobacterial activities, in comparison with the standards, namely, Gentamycin, Nystatin and Isoniazid, respectively. In overall bioassay (Table 1) in general the compounds 4, 5, 6c and 6d exhibited good antimicrobial potency against both types of test species. In (Table 2) 
Conclusion
This study reports the successful synthesis of some new nicotinic acid hydrazide derivatives. The antimicrobial screening studies were also performed in the study. The substituted pyrazole and oxadiazole are the active components present in many standard drugs and it is known to increase the pharmacological activity of the molecules. The antimicrobial screening suggests that among the newly synthesized compounds, 4, 5, 6c and 6d exhibited good activity against all the tested microorganisms and the antimycobacterial screening suggest that 4 and 6c exhibited good antimycobacterial activity against tested microorganism. 
